Protecting intellectual property (IP) is paramount to the success of Life Sciences entities.
Saul Ewing Arnstein & Lehr attorneys understand the risks you face when your IP and brand are threatened and they have deep experience helping clients protect them when disputes escalate into litigation. Our intellectual property team includes attorneys who serve as New Jersey litigation counsel in patent cases for more than two dozen major pharmaceutical and medical device companies. They have secured major national trial victories in ANDA (Abbreviated New Drug Application) cases where hundreds of millions of dollars in sales were at stake. Prior to its merger with Arnstein & Lehr, Saul Ewing was ranked fourth, nationally, for the number of cases handled involving patentee representation between 2015 and the first quarter of 2017, and fourth, nationally, for the number of cases involving ANDA plaintiff representation between 2009 and the first quarter of 2017. We also advocate for clients at emergent hearings for restraining orders and injunctions; advise on protecting proprietary markets and generating licensing revenue through assertion of IP rights; and enforce and defend IP rights pursuant to confidentiality agreements. In addition, the team includes attorneys with extensive experience in trademark and trade dress infringement, unfair competition and domain name cases in federal court and through alternative dispute resolution as well as opposition, cancellation, and concurrent use administrative proceedings before the Trademark Trial and Appeal Board.
Saul Ewing Arnstein & Lehr’s intellectual property litigators have experience advising:
- Pharmaceutical companies
- Medical device companies
- University research programs
- Industrial and consumer manufacturing companies
The group includes attorneys who have been named to the following lists:
- Chambers USA
- Super Lawyers